Supreme Court Upholds Mail Delivery of Abortions Pill
The U.S. Supreme Court dismissed a challenge to the FDA's approval of mifepristone. The Court ruled the pill can continue to be shipped directly to patients by mail. The decision came amid a wave of state-level attempts to restrict the drug. Plaintiffs argued the FDA exceeded its authority. The ruling preserves nationwide access for the foreseeable future.
The decision is a victory for women's rights and a check on state interference in health care.
The ruling shows the Court overstepping, ignoring states' rights to protect unborn life.
The Court reaffirmed federal authority over drug approvals, but the issue remains politically charged.